Morgan Stanley Cash & Equivalents increased by 19.5% to $133.53B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 47.2%, from $90.74B to $133.53B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows relatively stable performance with a 1.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $126.48B | $123.86B | $127.73B | $136.09B | $131.29B | $111.70B | $128.13B | $111.26B | $104.99B | $108.40B | $89.23B | $102.31B | $90.16B | $91.08B | $105.39B | $90.74B | $109.13B | $103.73B | $111.70B | $133.53B |
| QoQ Change | — | -2.1% | +3.1% | +6.5% | -3.5% | -14.9% | +14.7% | -13.2% | -5.6% | +3.2% | -17.7% | +14.7% | -11.9% | +1.0% | +15.7% | -13.9% | +20.3% | -4.9% | +7.7% | +19.5% |
| YoY Change | — | — | — | — | +3.8% | -9.8% | +0.3% | -18.2% | -20.0% | -2.9% | -30.4% | -8.0% | -14.1% | -16.0% | +18.1% | -11.3% | +21.0% | +13.9% | +6.0% | +47.2% |